Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A FitzGerald

Showing results (81-90 of 310) with videos related to

Pageof 31
Sort By:
Federation Proceedings|January 1, 1987
Thromboxane A2 biosynthesis in human diseaseG A FitzGerald, C Healy, J Daugherty
Clinical Pharmacology and Therapeutics|August 1, 1981
Norepinephrine release in essential hypertensionG A FitzGerald, V Hossmann, C T Dollery
The Journal of Biological Chemistry|August 24, 1999
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivoJ A Lawson, J Rokach, G A FitzGerald
Eicosanoids|January 1, 1992
Thromboxane synthase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesisR Dworski, G A FitzGerald, J R Sheller
The Journal of Clinical Investigation|November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosisD J Fitzgerald, J Fragetta, G A FitzGerald
Annals of the New York Academy of Sciences|November 15, 1994
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alphaD Pratico, J A Lawson, G A Fitzgerald
Hypertension (Dallas, Tex. : 1979)|January 1, 1981
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertensionV Hossmann, G A FitzGerald, C T Dollery
Irish Medical Journal|September 1, 1981
Sources of referral, costs and length of hospital stay in a teaching hospital: impact of a day care facilityG A FitzGerald, M Beggan, M I Drury
Blood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J Fitzgerald
British Medical Journal|August 6, 1977
Cryoglobulinaemia in Henoch-Schönlein purpuraG A Fitzgerald, C Crowe, M I Drury
Pageof 31

Showing results (81-90 of 310) with videos related to

Sort By:
Pageof 31
Federation Proceedings|January 1, 1987
Thromboxane A2 biosynthesis in human diseaseG A FitzGerald, C Healy, J Daugherty
Clinical Pharmacology and Therapeutics|August 1, 1981
Norepinephrine release in essential hypertensionG A FitzGerald, V Hossmann, C T Dollery
The Journal of Biological Chemistry|August 24, 1999
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivoJ A Lawson, J Rokach, G A FitzGerald
Eicosanoids|January 1, 1992
Thromboxane synthase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesisR Dworski, G A FitzGerald, J R Sheller
The Journal of Clinical Investigation|November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosisD J Fitzgerald, J Fragetta, G A FitzGerald
Annals of the New York Academy of Sciences|November 15, 1994
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alphaD Pratico, J A Lawson, G A Fitzgerald
Hypertension (Dallas, Tex. : 1979)|January 1, 1981
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertensionV Hossmann, G A FitzGerald, C T Dollery
Irish Medical Journal|September 1, 1981
Sources of referral, costs and length of hospital stay in a teaching hospital: impact of a day care facilityG A FitzGerald, M Beggan, M I Drury
Blood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J Fitzgerald
British Medical Journal|August 6, 1977
Cryoglobulinaemia in Henoch-Schönlein purpuraG A Fitzgerald, C Crowe, M I Drury
Pageof 31